Skip to main content
SP5007,711.76-0.25%DOW53,559.99-0.02%NASDAQ26,402.42-0.52%BTC$78,445.00-0.04%ETH$2,454.71-0.57%GOLD$4,507.20-0.50%OIL$86.33+3.51%
Smart Investors Daily
Sign InSign Up Free
Elevance Health Inc. logo

NASDAQ · ELV

Elevance Health Inc.

Healthcare · Medical - Healthcare Plans

$394.43

Down-$4.68 (-1.17%)

Updated Aug 31, 2026, 3:09 AM

SID Score

7.6/10

Composite research score

Smart Money

58/100

Neutral

Market cap
80.05B
P/E ratio
14.7
Dividend yield
1.73%
52-week range
$274.84 – $436.24
Volume
561.39K
Avg. volume
1.72M

Price performance

ELV price history

1M range · 20 trading sessions · Daily adjusted prices

ELV closed at $394.43 after 20 trading sessions, up 3.05% for the selected period.

Last close
$394.43
Period change
+3.05%
Period low
$378.00
Period high
$402.63
Daily close
View OHLC price history
ELV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 28, 2026$400.81$403.155$394.40$394.43561.39K
Aug 27, 2026$397.36$404.09$395.22$399.11569.34K
Aug 26, 2026$399.00$410.285$399.00$402.54683.86K
Aug 25, 2026$402.67$402.67$397.69$398.87933.56K
Aug 24, 2026$401.17$406.99$398.32$402.63805.54K
Aug 21, 2026$396.96$404.485$396.96$400.54771.59K
Aug 20, 2026$394.39$399.59$393.81$396.28812.92K
Aug 19, 2026$398.44$402.87$395.35$398.451.12M
Aug 18, 2026$394.46$402.7199$391.7713$398.27950.87K
Aug 17, 2026$396.82$400.17$388.12$390.24900.65K
Aug 14, 2026$398.39$402.30$397.23$400.32730.75K
Aug 13, 2026$400.80$404.72$397.63$398.22652.29K
Aug 12, 2026$386.94$399.16$385.84$399.14786.75K
Aug 11, 2026$398.22$403.33$388.16$390.37907.28K
Aug 10, 2026$395.31$400.9275$395.015$397.70854.59K
Aug 7, 2026$390.39$395.70$387.31$394.20942.13K
Aug 6, 2026$391.83$392.74$386.69$391.40910.92K
Aug 5, 2026$375.20$392.43$370.47$391.241.17M
Aug 4, 2026$381.02$382.735$376.38$378.001.44M
Aug 3, 2026$375.84$383.81$374.03$382.771.14M

Latest ELV news

The latest Smart Investors Daily articles mentioning ELV.

Stock researchCompany · Overview

ELV research

Overview

Company profile and research snapshot.

Company profile

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$389.63
Implied upside
—
Analysts
20
ELV recent ratings
DateFirmRatingTarget
Jul 17, 2026Leerink PartnersMarket Perform—
Jul 16, 2026Wells FargoOverweight—
Jul 16, 2026RBC CapitalSector Perform—
Jul 16, 2026GuggenheimBuy—
Jul 16, 2026BarclaysOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 27, 2026

Evaluating Elevance Health (ELV) After Prolonged Share Price Weakness And 17.3% Undervaluation Estimate

With no single headline event driving attention, Elevance Health (ELV) has drawn investor interest after a mixed share price record, including a 16.18% decline over the past year and a 27.89% decline over three years. See our latest analysis for Elevance Health. Recent trading has been soft, with a 7 day share price return of 7.22% and a year to date share price return decline of 8.81%, while the 1 year total shareholder return decline of 16.18% and 3 year total shareholder return decline of...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By